[HTML][HTML] Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?
Colorectal cancer commonly metastasizes. The liver is the most frequent site of metastases
and dominates the length of survival for this disease. As surgical and systemic therapies …
and dominates the length of survival for this disease. As surgical and systemic therapies …
The molecular biology of peritoneal metastatic disease
S Bootsma, MF Bijlsma, L Vermeulen - EMBO molecular medicine, 2023 - embopress.org
Peritoneal metastases are a common form of tumor cell dissemination in gastrointestinal
malignancies. Peritoneal metastatic disease (PMD) is associated with severe morbidity and …
malignancies. Peritoneal metastatic disease (PMD) is associated with severe morbidity and …
Peritoneal metastases from colorectal cancer: defining and addressing the challenges
O Kranenburg, K Speeten, I Hingh - Frontiers in oncology, 2021 - frontiersin.org
The presence of peritoneal metastases (PM) in patients with colorectal cancer (CRC) is
associated with an extremely poor prognosis. The diagnosis of PM is challenging, resulting …
associated with an extremely poor prognosis. The diagnosis of PM is challenging, resulting …
Fibroblast activation protein identifies Consensus Molecular Subtype 4 in colorectal cancer and allows its detection by 68Ga-FAPI-PET imaging
E Strating, E Wassenaar, M Verhagen… - British journal of …, 2022 - nature.com
Background In colorectal cancer (CRC), the consensus molecular subtype 4 (CMS4) is
associated with therapy resistance and poor prognosis. Clinical diagnosis of CMS4 is …
associated with therapy resistance and poor prognosis. Clinical diagnosis of CMS4 is …
Site of recurrence and survival after surgery for colorectal peritoneal metastasis
E Breuer, M Hebeisen, MA Schneider… - JNCI: Journal of the …, 2021 - academic.oup.com
Background Multimodal treatment, including systemic treatment and surgery, improved the
prognosis of peritoneal metastasis (PM). Despite all efforts, recurrence rates remain high …
prognosis of peritoneal metastasis (PM). Despite all efforts, recurrence rates remain high …
Logic gate-driven dual-index balanced visualization strategy for tumor metastasis diagnosis
P Yu, W Chen, L Ge, J Fang, X Huang, H Tong… - Biosensors and …, 2023 - Elsevier
Exfoliated tumor cells are integral to malignant tumors diagnosis. The process of clinical
cytology of exfoliation involves several complex steps that require at least two days of …
cytology of exfoliation involves several complex steps that require at least two days of …
Role of Tumor-informed Personalized Circulating Tumor DNA Assay in Informing Recurrence in Patients With Peritoneal Metastases From Colorectal and High-grade …
Objective: To investigate the role of a personalized, tumor-informed circulating tumor DNA
(ctDNA) assay in informing recurrence in patients with peritoneal metastases (PM) from …
(ctDNA) assay in informing recurrence in patients with peritoneal metastases (PM) from …
The multivisceral landscape of colorectal cancer metastasis: implications for targeted therapies
D Wolf, S Salcher, A Pircher - The Journal of Clinical …, 2024 - Am Soc Clin Investig
Colorectal cancer (CRC) is among the most common cancer types and the second deadliest
malignancy for both sexes. Metastatic disease poses substantial therapeutic challenges …
malignancy for both sexes. Metastatic disease poses substantial therapeutic challenges …
Impact of enhanced recovery after surgery on postoperative outcomes for patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
B White, F Dahdaleh, SA Naffouje, N Kothari… - Annals of Surgical …, 2021 - Springer
Background Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy
(HIPEC) have been associated with significant morbidity and increased hospital length of …
(HIPEC) have been associated with significant morbidity and increased hospital length of …
Metastatic Colon Cancer Treatment Using S100A9-Targeted Cowpea Mosaic Virus Nanoparticles
YH Chung, BA Volckaert, NF Steinmetz - Biomacromolecules, 2022 - ACS Publications
Peritoneal metastases (PMs) occur due to the metastasis of gynecological and
gastrointestinal cancers such as ovarian, colon, pancreatic, or gastric tumors. PM outgrowth …
gastrointestinal cancers such as ovarian, colon, pancreatic, or gastric tumors. PM outgrowth …